Ovation Science Inc.
OVATF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $3 | $3 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -18.5% | -5% | 8.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.7% | 99.9% | 97.9% | 79.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -652.3% | -754.1% | -562.9% | -97% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -710% | -802.1% | -694.1% | -163.2% |
| EPS Diluted | -0.003 | -0.004 | -0.004 | -0.001 |
| % Growth | 28.9% | -8.6% | -400% | – |
| Operating Cash Flow | – | -$0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$0 | $0 | $0 |